List of Excipients in API hydroxyprogesterone caproate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydroxyprogesterone caproate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AMAG Pharmaceuticals Inc | MAKENA | hydroxyprogesterone caproate | 64011-243 | BENZYL ALCOHOL | |
| AMAG Pharmaceuticals Inc | MAKENA | hydroxyprogesterone caproate | 64011-243 | BENZYL BENZOATE | |
| AMAG Pharmaceuticals Inc | MAKENA | hydroxyprogesterone caproate | 64011-243 | CASTOR OIL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing hydroxyprogesterone caproate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| American Regent Inc | hydroxyprogesterone caproate | 0517-1767 | BENZYL BENZOATE |
| American Regent Inc | hydroxyprogesterone caproate | 0517-1767 | CASTOR OIL |
| American Regent Inc | hydroxyprogesterone caproate | 0517-1791 | BENZYL BENZOATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for hydroxyprogesterone caproate
Excipient focus: BENZYL ALCOHOL
hydroxyprogesterone caproate drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | hydroxyprogesterone caproate | 47335-037 |
| AuroMedics Pharma LLC | hydroxyprogesterone caproate | 55150-310 |
| AuroMedics Pharma LLC | hydroxyprogesterone caproate | 55150-311 |
| >Company | >Ingredient | >NDC |
hydroxyprogesterone caproate drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| American Regent Inc | hydroxyprogesterone caproate | 0517-1767 |
| American Regent Inc | hydroxyprogesterone caproate | 0517-1791 |
| AuroMedics Pharma LLC | hydroxyprogesterone caproate | 55150-309 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZYL BENZOATE
hydroxyprogesterone caproate drug variants containing BENZYL BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| American Regent Inc | hydroxyprogesterone caproate | 0517-1767 |
| American Regent Inc | hydroxyprogesterone caproate | 0517-1791 |
| Sun Pharmaceutical Industries Inc | hydroxyprogesterone caproate | 47335-037 |
| >Company | >Ingredient | >NDC |
hydroxyprogesterone caproate drug variants not containing BENZYL BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: CASTOR OIL
hydroxyprogesterone caproate drug variants containing CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| American Regent Inc | hydroxyprogesterone caproate | 0517-1767 |
| American Regent Inc | hydroxyprogesterone caproate | 0517-1791 |
| Sun Pharmaceutical Industries Inc | hydroxyprogesterone caproate | 47335-037 |
| >Company | >Ingredient | >NDC |
hydroxyprogesterone caproate drug variants not containing CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
